Literature DB >> 8349731

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

J M Ervasti1, K P Campbell.   

Abstract

The dystrophin-glycoprotein complex was tested for interaction with several components of the extracellular matrix as well as actin. The 156-kD dystrophin-associated glycoprotein (156-kD dystroglycan) specifically bound laminin in a calcium-dependent manner and was inhibited by NaCl (IC50 = 250 mM) but was not affected by 1,000-fold (wt/wt) excesses of lactose, IKVAV, or YIGSR peptides. Laminin binding was inhibited by heparin (IC50 = 100 micrograms/ml), suggesting that one of the heparin-binding domains of laminin is involved in binding dystroglycan while negatively charged oligosaccharide moieties on dystroglycan were found to be necessary for its laminin-binding activity. No interaction between any component of the dystrophin-glycoprotein complex and fibronectin, collagen I, collagen IV, entactin, or heparan sulfate proteoglycan was detected by 125I-protein overlay and/or extracellular matrix protein-Sepharose precipitation. In addition, laminin-Sepharose quantitatively precipitated purified dystrophin-glycoprotein complex, demonstrating that the laminin-binding site is accessible when dystroglycan is associated with the complex. Dystroglycan of nonmuscle tissues also bound laminin. However, the other proteins of the striated muscle dystrophin-glycoprotein complex appear to be absent, antigenically dissimilar or less tightly associated with dystroglycan in nonmuscle tissues. Finally, we show that the dystrophin-glycoprotein complex cosediments with F-actin but does not bind calcium or calmodulin. Our results support a role for the striated muscle dystrophin-glycoprotein complex in linking the actin-based cytoskeleton with the extracellular matrix. Furthermore, our results suggest that dystrophin and dystroglycan may play substantially different functional roles in nonmuscle tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349731      PMCID: PMC2119587          DOI: 10.1083/jcb.122.4.809

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  88 in total

1.  Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel.

Authors:  T Imagawa; J S Smith; R Coronado; K P Campbell
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

2.  Immunoelectron microscopic localization of dystrophin in myofibres.

Authors:  S C Watkins; E P Hoffman; H S Slayter; L M Kunkel
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

3.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

4.  Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.

Authors:  A H Sharp; T Imagawa; A T Leung; K P Campbell
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

5.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.

Authors:  K Matsumura; I Nonaka; K P Campbell
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

7.  Mucin-like glycoprotein secreted by cultured hamster tracheal epithelial cells. Biochemical and immunological characterization.

Authors:  R Wu; C G Plopper; P W Cheng
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

8.  Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells.

Authors:  D J Blake; D R Love; J Tinsley; G E Morris; H Turley; K Gatter; G Dickson; Y H Edwards; K E Davies
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

9.  Isolation and partial characterization of high affinity laminin receptors in neural cells.

Authors:  P J Douville; W J Harvey; S Carbonetto
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

10.  A vertebrate actin-related protein is a component of a multisubunit complex involved in microtubule-based vesicle motility.

Authors:  J P Lees-Miller; D M Helfman; T A Schroer
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

View more
  439 in total

1.  Presence of a laminin-binding chondroitin sulfate proteoglycan at the cell surface of a human melanoma cell Mel-85.

Authors:  M C Elias; S S Veiga; W Gremski; M A Porcionatto; H B Nader; R R Brentani
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells.

Authors:  J Muschler; A Lochter; C D Roskelley; P Yurchenco; M J Bissell
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

3.  Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin.

Authors:  D Tisi; J F Talts; R Timpl; E Hohenester
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

4.  The dystrophin-associated glycoprotein complex: what parts can you do without?

Authors:  H L Sweeney; E R Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

6.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

7.  The interaction with HMG20a/b proteins suggests a potential role for beta-dystrobrevin in neuronal differentiation.

Authors:  Benedetta Artegiani; Catherine Labbaye; Antonella Sferra; Maria Teresa Quaranta; Paola Torreri; Gianfranco Macchia; Marina Ceccarini; Tamara C Petrucci; Pompeo Macioce
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

8.  Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.

Authors:  Peng Zhang; Huaiyu Hu
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

9.  Patterning, prestress, and peeling dynamics of myocytes.

Authors:  Maureen A Griffin; Adam J Engler; Thomas A Barber; Kevin E Healy; H Lee Sweeney; Dennis E Discher
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

10.  Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.

Authors:  Eugene J Wyatt; Alexis R Demonbreun; Ellis Y Kim; Megan J Puckelwartz; Andy H Vo; Lisa M Dellefave-Castillo; Quan Q Gao; Mariz Vainzof; Rita C M Pavanello; Mayana Zatz; Elizabeth M McNally
Journal:  JCI Insight       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.